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ABSTRACT The advent of genome editing techniques based on the clustered regularly interspersed short palindromic repeats
(CRISPR)–Cas9 system has revolutionized research in the biological sciences. CRISPR is quickly becoming an indispensible experimental
tool for researchers using genetic model organisms, including the nematode Caenorhabditis elegans. Here, we provide an overview of
CRISPR-based strategies for genome editing in C. elegans. We focus on practical considerations for successful genome editing,
including a discussion of which strategies are best suited to producing different kinds of targeted genome modifications.
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A fundamental goal of biological research is to understandthe functions of genes. One common strategy for study-
ing gene function is to observe the phenotypes of mutants to
deduce the biological processes in which a gene participates
and, sometimes, details of its mechanism of action. This basic
idea is the foundation of classical genetics and also under-
lies reverse genetic approaches including RNAi. A second
strategy is to observe the localization and dynamics of a
gene’s protein product within a cell or animal, either by
antibody staining or by expressing a fluorescent protein
(FP) fusion. Together, these two basic strategies form the
backbone of much research in Caenorhabditis elegans and
other model systems.
The use of the clustered regularly interspaced short palin-
dromic repeats (CRISPR)-Cas9 system for genome engineering
(Hsu et al. 2014) has greatly facilitated the study of gene func-
tion in Caenorhabditis elegans and other organisms. By making
precisely targeted mutations in endogenous genes, an investi-
gator can examine the relationship between gene function and
phenotype. By inserting coding sequence for a fluorescent pro-
tein, the expression and localization of endogenous proteins
can be monitored. In both cases, one avoids the caveats of
overexpression and silencing that are associated with conven-
tional transgenes. Moreover, for fluorescent protein (FP) fu-
sions, insertion of the FP into the endogenous locus allows one
to use phenotypic assays to quickly determine whether the
resulting fusion protein is functional. Together, these advan-
tages permit more carefully controlled experiments to be done
and thus allow greater confidence in the results. As an added
benefit, current CRISPR-based approaches (Arribere et al.
2014; Dickinson et al. 2015; Paix et al. 2015; Ward 2015)
are faster and require less labor than either conventional trans-
genesis (Mello et al. 1991) or microparticle bombardment
(Praitis et al. 2001), and they eliminate the need for special-
ized strain backgrounds that are required for these
methods and those based on the Mos1 transposon (Robert
and Bessereau 2007; Frøkjaer-Jensen et al. 2008, 2010, 2012).
Many different CRISPR approaches have been developed
for C. elegans and are being widely adopted by the research
community. In general, all of these methods work well, with
different strategies being best suited to different experimen-
tal goals. By choosing the appropriate strategy, one can now
make essentially any desired change to the C. elegans genome
in a matter of days to weeks, with ,1 day of hands-on labor
(Dickinson et al. 2013, 2015; Arribere et al. 2014; Zhao et al.
2014; Paix et al. 2015; Ward 2015). The goal of this article is
to aid users in choosing the best strategy for a given applica-
tion. We provide an overview of CRISPR-based methods for
C. elegans, including a discussion of which strategies are most
appropriate for generating different kinds of modifications.
Overview of the CRISPR-Cas9 system
Cas9 is an endonuclease found in Archaea and some bacteria,
where it is involved in adaptive immunity against phages and
plasmids (Hsu et al. 2014). Unlike restriction endonucleases,
whose protein structures recognize particular DNA sequences
(e.g., EcoRI recognizes GAATTC), the specificity of Cas9 is
determined by the sequence of an associated small RNA mol-
ecule (Figure 1) (Jinek et al. 2012). In its native context,
bacterial Cas9 binds two small RNAs: a CRISPR RNA (crRNA)
that determines target specificity and a trans-activating
CRISPR RNA (tracrRNA) that base pairs with the crRNA
and activates the Cas9 enzyme. The two RNA molecules
can be fused to generate a chimeric single guide RNA (sgRNA)
that supports Cas9 cleavage of DNA substrates (Jinek et al.
2012). The 20-bp guide sequence at the 59 end of the sgRNA
directly determines the sequence cleaved by Cas9, by forming
Watson–Crick base pairs with the DNA target (Figure 1). In
addition to this base-pairing interaction, Cas9 must interact
with a protospacer-adjacent motif (PAM) on the target DNA
molecule. The PAM sequence NGG is recognized by Strepto-
coccus pyogenes (Sp) Cas9, which is the Cas9 most frequently
used in the laboratory. Thus, SpCas9 can be programmed to
cleave any desired nucleotide sequence that contains a GG
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dinucleotide, by simply changing the sequence at the 59 end
of the sgRNA. It is this ease of programming that makes Cas9
such a powerful and flexible tool for genome engineering.
More recently, engineered derivatives of SpCas9 have been
described that recognize alternate PAMs including NGA,
NGAG, and NGCG (Kleinstiver et al. 2015), and some of these
have been tested and shown to be effective in C. elegans (Bell
et al. 2015). Cas9 homologs from bacterial species other than
S. pyogenes have also been found to recognize alternate PAMs
(Ran et al. 2015). Also, the unrelated CRISPR nuclease Cpf1
recognizes its targets differently from Cas9 and has been suc-
cessfully used for genome editing inmammalian cells (Zetsche
et al. 2015). Although Cpf1 and non-Sp Cas9 homologs have
not yet been tested in C. elegans to our knowledge, it seems
likely that a growing collection of RNA-guided nucleases rec-
ognizing a wider variety of PAMs than the conventional NGG
will become available in the next few years.
It is important for a user of Cas9 to have some understand-
ingof thedifferent roles that theguide sequenceandPAMplay
in determining Cas9 specificity. When searching for a sub-
strate, Cas9 first binds to the PAM and only then interrogates
the adjacent DNA to look for a match to the guide sequence
(Sternberg et al. 2014). Thus, even DNA sequences that per-
fectly match the guide sequence are not recognized or
cleaved if they do not contain a PAM. The requirement for
an NGG PAM sequence appears fairly stringent (Jinek et al.
2012; Kuscu et al. 2014; Sternberg et al. 2014; Wu et al.
2014), although an NAG sequence may be able to support
low-efficiency cleavage in some instances (Hsu et al. 2013;
Jiang et al. 2013). In contrast to its strict requirement for the
PAM sequence, Cas9 is somewhat tolerant of mismatches be-
tween the guide sequence and the target, especially when
they occur near the 59 end of the guide sequence (i.e., distal
to the PAM) (Jinek et al. 2012; Fu et al. 2013; Hsu et al. 2013;
Pattanayak et al. 2013; Kuscu et al. 2014; Ren et al. 2014; Wu
et al. 2014). The practical consequences of this mismatch
tolerance are discussed in Addressing Cas9 Specificity, below.
Genome engineering via double-strand break repair
As described above in Overview of the CRISPR-Cas9 system,
Cas9 can be used to generate a DNA double-strand break at a
defined location in the genome. These double-strand breaks
are useful because they allow an investigator to make use of
endogenous cellular DNA repair machinery to generate cus-
tom modifications in the genome. Three different types of
DNA repair strategies have been used to produce custom
modifications in C. elegans (Figure 2):
1. Error-prone repair via end joining: When Cas9 cleaves ge-
nomic DNA, some of the resulting DNA double-strand
breaks are repaired by an error-prone pathway that pro-
duces small insertions or deletions (indels) at the site of
the break. Mechanistically, these indels arise not via ca-
nonical nonhomologous end joining (NHEJ) as had been
widely assumed, but from an alternative end-joining path-
way that requires DNA polymerase Q (van Schendel et al.
2015). When generated in protein-coding sequence,
indels can shift the reading frame, resulting in a prema-
ture stop codon. Thus, error-prone repair can be used to
produce loss-of-function alleles (C. Chen et al. 2013; Chiu
et al. 2013; Cho et al. 2013; Friedland et al. 2013; Katic
and Großhans 2013; Lo et al. 2013; Waaijers et al. 2013).
2. Homology-directed repair: In homology-directed repair
(HDR), an exogenous DNA molecule is introduced along
with Cas9 and serves as a template for DNA repair. Mod-
ifications present in the repair template are copied into the
genome in an error-free manner. Different kinds of repair
templates have been reported to yield different HDR effi-
ciencies in C. elegans (Arribere et al. 2014; Paix et al. 2014,
2015; Dickinson et al. 2015; Ward 2015). For insertions
up to 1 kb, repair was most efficient when the repair
template contained 30–40 bp of homology to the genome,
and longer homology arms led to reduced efficiency (Paix
et al. 2014). On the other hand, insertions of 6 kb were
readily obtained using 500- to 700-bp homology arms, but
occurred rarely or not at all when using 30- to 40-bp ho-
mology arms (Dickinson et al. 2015). Based on these ob-
servations, there appear to be two distinct HDR pathways
in C. elegans, which we call short-range HDR and long-
range HDR. For convenience, we discuss these two repair
pathways as if they occur via different mechanisms (as
proposed in Figure 2), although the actual molecular
mechanisms are not yet known.
2a. Short-range HDR is a highly local repair mechanism
that occurs most efficiently within10 bp of the Cas9
cut site (Arribere et al. 2014; Paix et al. 2015; Ward
2015) and when the repair template carries 30- to
40-bp homology arms flanking the desired modifica-
tion (Arribere et al. 2014; Paix et al. 2014; Ward
2015). Short-range HDR can be very efficient in C.
elegans: in the best cases, .50% of F1 progeny that
received active Cas9 and the repair template can
carry short-range HDR events. Short-range HDR
can be used to introduce point mutations, precise
Figure 1 DNA recognition by the Cas9–sgRNA complex. Cas9 identifies
its substrates by first binding to the PAM (NGG motif) and subsequently
by base pairing of the sgRNA cofactor to the substrate DNA. HNH
and RuvC are the two Cas9 nuclease domains that cleave the sgRNA-
complementary and noncomplementary strand of the target DNA, respec-
tively. Red and orange in the sgRNA indicate the portions derived from the
bacterial crRNA and tracrRNA, respectively.
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deletions, and small epitope tags by using a single-
stranded DNA oligonucleotide as the repair template
(Paix et al. 2014; Zhao et al. 2014). Larger insertions
such as GFP insertion can also be made via short-range
HDR, using a PCR product as the repair template (Paix
et al. 2014, 2015). The main advantages of short-range
HDR are its high efficiency and the fact that only 30–40
bp of homology to the genome are required for efficient
repair. Short-range HDR has two main limitations. First,
it occurs most efficiently within 10 bp of a Cas9 cleavage
site, and efficiency declines sharply at larger distances
(Arribere et al. 2014; Paix et al. 2015; Ward 2015). This
can make it challenging to isolate edits that are not
located near an efficient sgRNA target site (see Choosing
a Cas9 target site, below, for a discussion of factors gov-
erning sgRNA efficiency). Second, for reasons that re-
main unclear, short-range HDR cannot accommodate
insertions much larger than 1–2 kb (Dickinson et al.
2015; Paix et al. 2015); thus, short-range HDR is suitable
for GFP insertion but not for larger-scale modifications.
2b. Long-range HDR allows insertion of much larger se-
quences [at least 12 kb (Das et al. 2015)] and at a
greater distance from the cut site [at least 1 kb (Dickinson
et al. 2013; Das et al. 2015; Sullivan-Brown et al.
2016)]. Plasmids carrying 500–1500 bp of genomic ho-
mology flanking the desired modifications are robust
substrates for this repair mechanism (Dickinson et al.
2013, 2015). On a per-F1 basis, long-range HDR is
much less efficient than short-range HDR; however, be-
cause it can accommodate larger inserts, long-range
HDR allows use of selectable markers, which offset
the lower efficiency by facilitating quick and easy iden-
tification of repair events. Long-range HDR is relatively
insensitive to variations in sgRNA efficiency (Dickinson
et al. 2015), presumably because the repair process
itself, rather than Cas9 cleavage, is the limiting factor.
The different properties of short-range vs. long-range HDR
influence both the experimental design and the types of mod-
ifications that each strategy is best suited to generate, as
discussed in the following sections.
Four basic steps for genome engineering with Cas9
To generate custom genome modifications with CRISPR/
Cas9 in any experimental system, one must accomplish four
basic tasks: (1) introduce Cas9 and an appropriately targeted
sgRNA; (2) if using HDR, supply the appropriate repair tem-
plate; (3) identify the animals that carry the desired genome
modification; and (4) address specificity, since Cas9 can
generate off-target mutations under some conditions.
The next four sections discuss how each of these steps
can be accomplished in C. elegans. Then, in Recommended
Figure 2 DNA repair approaches for CRISPR-based genome engineering. DNA double-strand breaks introduced by Cas9 can be repaired via three
different mechanisms. End joining produces random insertion/deletion mutations. HDR produces error-free edits using an exogenous DNA molecule as a
repair template. Although the mechanisms of HDR in C. elegans are not known, efficiency data suggest the existence of two different HDR pathways
(see text). Short-range HDR is hypothesized to occur via a synthesis-dependent strand-annealing mechanism and can accommodate insertions of up to
1–2 kb, with the highest efficiency within 10 bp of the cut site. Long-range HDR is hypothesized to occur via a double-crossover mechanism and can
accommodate insertions of at least 12 kb, at distances up to at least 1 kb from the cut site.
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Strategies for Different Types of Modifications, we recommend
approaches to generate different kinds of custom alleles with
minimal time and labor.
Using Cas9 to Generate DNA Double-Strand Breaks
Expression of Cas9 and sgRNA in C. elegans
Cas9 can be easily expressed in theC. elegans germline by inject-
ing an expression plasmid (Dickinson et al.2013; Friedland et al.
2013) or messenger RNA (mRNA) (Chiu et al. 2013; Katic and
Großhans 2013; Lo et al. 2013). Alternatively, purified Cas9
proteinmay be reconstitutedwith its RNA cofactors and directly
injected into the gonad of the worm (Cho et al. 2013; Paix et al.
2015). For plasmid-based germline expression of Cas9, the eft-3
promoter (Frøkjaer-Jensen et al. 2012) has been widely used.
By substituting heat-shock or tissue-specific promoters for Peft-
3, it is possible to generate indels in somatic tissue, producing
tissue specific loss-of-function phenotypes (Liu et al. 2014; Shen
et al. 2014). Generally speaking, it appears that transgenic ex-
pression of Cas9 can be easily achieved using the same basic
approaches that are well established for other transgenes.
Similarly, sgRNA can be either expressed from a plasmid or
synthesized in vitro and injected. A third option is to feed the
worms bacteria expressing sgRNA, which has low efficiency
compared to other methods but may be useful for high-
throughput screening (Liu et al. 2014). Plasmid-based sgRNA
expression constructs use a U6 promoter, which directs tran-
scription by RNA polymerase III (C. Chen et al. 2013;
Dickinson et al. 2013; Friedland et al. 2013). U6 snRNA is
an essential component of the mRNA splicing machinery and
thus would be expected to be ubiquitously expressed. Con-
sistent with this prediction, PU6::sgRNA constructs have been
successfully used to produce mutations both in the germline
and in somatic tissues (C. Chen et al. 2013; Dickinson et al.
2013; Friedland et al. 2013; Shen et al. 2014). Note that two
independently identified U6 promoters have been used in
published work (Dickinson et al. 2013; Friedland et al.
2013). Although CRISPR mutations have been successfully
isolated using sgRNAs expressed from both promoters, two
studies have reported conflicting observations of higher effi-
ciency with one promoter or the other (Farboud and Meyer
2015; Katic et al. 2015), suggesting that the choice of pro-
moter might influence editing efficiency in some cases. For
direct RNA injection, the RNA may be synthesized or pur-
chased commercially. Note that if RNA is chemically synthe-
sized commercially, it is more cost-effective to purchase
separate crRNA and tracrRNA rather than the longer chime-
ric sgRNA, because only the crRNA is specific to a given ex-
periment, while the tracrRNA sequence is constant.
The choice of whether to use plasmid-based Cas9 and
sgRNA expression or direct Cas9 and RNA injection will de-
pend on the needs of each individual user. Plasmid injection is
simple, reliable, and familiar to most C. elegans researchers.
However, this approach requires cloning each new guide se-
quence into an expression construct, and a relatively large
number of animals (50–60 in our experience) need to be
injected to consistently obtain the desired modification. Di-
rect injection of Cas9 ribonucleoprotein complexes yields a
higher frequency of successful injections compared to plasmid-
based expression, thus reducing the number of animals that
need to be injected to as few as 10 (Paix et al. 2015). The
trade-off is that the user must either purchase Cas9 protein
and the required small RNAs or purify them in house. Pur-
chasing Cas9 protein, tracrRNA, and crRNA is currently quite
costly ($200 per target, with most of the cost going to the
synthetic RNAs), but the cost may drop as more commercial
sources become available, and the ability to inject fewer
worms may justify the cost for some users.
Cas9andsgRNAexpressionplasmids fromseveraldifferent
laboratories are available from Addgene (http://www.
addgene.org/CRISPR/worm/). Escherichia coli expression
vectors for producing Cas9 protein are also available
(http://www.addgene.org/crispr/bacteria/).
Choosing a Cas9 target site
The first step in any CRISPR strategy is to choose the Cas9
target site. First, one needs to identify the general region to be
targeted. To generate loss-of-function indel mutations, one
should target a region close to the 59 end of the coding region
of the gene of interest, to maximize the chances that an indel
will abolish the function of the gene. For HDR-based strate-
gies, it is best to choose a site as close as possible to where the
desired modification will be made.
Once the general region to be targeted has been identi-
fied, the next step is to identify the actual guide sequence
within the target region. Three considerations govern the
choice of a guide sequence: activity, specificity, and proximity
to the desired modification. The relative importance of these
considerations depends on the repair mechanism and screen-
ing strategy being used (see Strategies for Identifying CRISPR
Modifications, below, for discussion of screening strategies).
For long-range HDR with a selectable marker, specificity
is the primary concern; for short-range HDR, activity and
proximity to the desired modification are more important.
Specificity: Ideally, one should select a guide sequence that
is unique in the genome, to minimize the chances of gen-
erating off-target mutations. We identify specific guide
sequences, using a CRISPR design tool developed by Feng
Zhang’s laboratory (Hsu et al. 2013) and available at
http://crispr.mit.edu. This tool lists all possible guide se-
quences within a 100- to 200-bp target region and iden-
tifies potential off-target cleavage sites for each guide.
Each guide is assigned a specificity score from 0 to 100
(with a score 100 indicating perfect specificity). In our
experience, for most 100- to 200-bp target regions in the
C. elegans genome there are at least two to three possible
guides with a score.95, indicating very good specificity. If
more than one highly specific guide is available, we choose
from among these based on predicted activity and proxim-
ity to our desired modification.
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Activity: Different guide sequences support different Cas9
cleavage efficiencies (Doench et al. 2014; Wang et al. 2014;
Farboud and Meyer 2015; Xu et al. 2015). Whether cleavage
efficiency is an important experimental consideration de-
pends on the screening strategy being used (see Strategies
for Identifying CRISPR Modifications, below). When using
long-range HDRwith a selectable marker, variations in cleav-
age efficiency are of no practical consequence because the
repair process, rather than Cas9 cleavage efficiency, is the
limiting factor. On the other hand, for short-range HDR,
cleavage activity is a critical determinant of efficiency, and
so it may beworthwhile to choose a slightly less specific guide
to achieve higher cleavage efficiency.
Guide sequences ending in GG (not to be confused with the
NGG PAM motif) have been shown to have consistently high
cleavage efficiency in C. elegans (Farboud and Meyer 2015).
However, these “39GG guides” occur only once every 128 bp in
random sequence (and even more infrequently in the AT-rich
C. elegans genome), so using a 39GG guide is usually not fea-
sible. As an alternative, several prediction algorithms have
been developed that may be useful for identifying the most
active guide sequences (Doench et al. 2014; Liu et al. 2015; Xu
et al. 2015). As of this writing, our preferred prediction tool
is SSC, which is available at http://crispr.dfci.harvard.edu/
SSC/. In general, guide sequences that are rich in G residues
and lack pyrimidines in the last four bases before the PAM tend
to be most active. Guides containing four or more consecutive
T/U bases should be avoided, as these stretches can prema-
turely terminate PolIII transcription. Cleavage efficiency can
also be improved by using an engineered sgRNA, termed
sgRNA(F+E) (B. Chen et al. 2013; Ward 2015).
Proximity to the desired modification: For short-rangeHDR
using an oligonucleotide or PCR product repair template (see
PCR screening and Co-CRISPR), the Cas9 target site should
ideally be within 10 bp of the desired modification (Arribere
et al. 2014; Paix et al. 2014, 2015). It is sometimes necessary
to choose a less specific and/or less active guide to achieve
this degree of proximity. For long-range HDR with a select-
able marker (see Positive selectable markers), proximity is
much less important, since efficient editing can be achieved
at least 1 kb from the Cas9 target site (Dickinson et al. 2013;
Das et al. 2015; Sullivan-Brown et al. 2016).
Once a guide sequence has been selected, it must be either
cloned into an appropriate sgRNA vector (a U6 promoter
vector for plasmid-based expression in C. elegans or a T7 pro-
moter vector for in vitro transcription) or synthesized com-
mercially for direct injection. The U6 promoter requires a G
residue as the first base of the sgRNA sequence to initiate
transcription, while for the T7 promoter, the sgRNA should
typically begin with GG. If these guanine residues are not
present in the chosen guide sequence, they can either be
substituted for the most 59 residues in the guide, since mis-
matches at these positions are well tolerated (Jinek et al.
2012; Fu et al. 2013; Hsu et al. 2013; Pattanayak et al.
2013; Kuscu et al. 2014; Ren et al. 2014; Wu et al. 2014),
or simply appended to the 59 end of the guide, since exten-
sions of the sgRNA beyond 20 bp do not affect cleavage ac-
tivity (Ran et al. 2013; Farboud and Meyer 2015). Both of
these approaches have succeeded in our laboratory.
Strategies for Identifying CRISPR Modifications
Choosing an appropriate selection or screening approach is
perhaps the most critical step in planning a new CRISPR
genome modification. Different strategies have been devised
that vary greatly in their applicability, efficiency, anddifficulty.
Each approach has strengths that are appropriate for different
applications. We summarize each strategy here; Recom-
mended Strategies for Different Types ofModifications provides
recommendations for which strategy to use for different
applications.
Screening based on mutant phenotype
The first demonstrations of Cas9-induced mutations in
C. elegans involved simple visual screening for obvious mu-
tant phenotypes such as Dpy or Unc, benomyl resistance con-
ferred by ben-1 mutations, or loss of fluorescence from a
bright GFP transgene (C. Chen et al. 2013; Chiu et al. 2013;
Cho et al. 2013; Friedland et al. 2013; Katic and Großhans
2013; Lo et al. 2013; Waaijers et al. 2013). While these were
useful proof-of-principle experiments, many genome modi-
fications that are of biological interest do not confer a visible
plate-level phenotype. Nevertheless, phenotype-based screen-
ing for edits at one locus can be used to enrich for edits
at a second locus in “co-CRISPR” approaches (described in
Co-CRISPR section).
There have also been reports of isolation of GFP knock-in
strains by visually screening forfluorescenceof the introduced
GFP (Kim et al. 2014; Paix et al. 2014, 2015). Although fluo-
rescence-based screening can clearly be effective in these
reported cases, it requires that the gene being tagged be
expressed at a high enough level that the GFP fusion protein
is easily visible on a dissecting microscope at reasonably low
magnification. Fluorescence-based screening is also greatly
facilitated when the pattern of protein expression is known in
advance. In our experience, the majority of C. elegans genes
do not meet these criteria, and so screening for knock-ins
based on visual examination of fluorescence is not an advis-
able strategy in general. It is possible in principle that dimmer
knock-ins could be isolated using a flow-sorting system
(Pulak 2006) or another automated system, but we are un-
aware of any reports of such an approach.
PCR screening
For mutations that do not produce an obvious plate pheno-
type, directly screening the F1 progeny of injected animals by
single-worm PCR is the simplest, but also by far the most
labor-intensive strategy. Several hundred F1 animals are
singled to new plates, allowed to lay eggs, and then pro-
cessed for PCR to identify animals heterozygous for the de-
sired genome modification. F2 progeny of positive F1’s are
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then singled and the process is repeated to identify homozy-
gotes. Direct PCR screening has now been essentially replaced
by co-CRISPR (see Co-CRISPR section), which greatly reduces
the number of animals that need to be screened.
Primer design for PCR screening depends on the nature of
the genome modification (Paix et al. 2014). HDR insertions
large enough to accommodate a PCR primer can be detected
using a primer inside the insertion and a second primer out-
side the homology arm. Large deletions can be detected with
flanking primers. For small indels or pointmutations, it is best
if the mutation introduces (or deletes) a unique restriction
site, which enables screening by restriction fragment length
polymorphism (RFLP). When performing HDR, a restriction
site can often be introduced into the repair template by mak-
ing silent substitutions in addition to themutation of interest.
If RFLP is not possible, the final choice is to screen by looking
for a mobility shift of PCR products on polyacrylamide gels
(Kim et al. 2014) or by using a nuclease that detects mis-
matches when wild-type and mutant PCR products are
annealed (Cong et al. 2013; Ward 2015).
Co-CRISPR
Co-CRISPR (Arribere et al. 2014; Kim et al. 2014;Ward 2015)
is a screening strategy that uses a visible phenotype at one
locus to help identify edits at a second locus. Two loci are
edited simultaneously: the locus of interest and an unlinked
marker locus that produces a visible phenotype (Figure 3).
The marker mutation is used to identify F1 animals derived
from oocytes that received active Cas9. Among all F1 progeny
of injected animals, those that received active Cas9 are most
likely to carry the desired modification (Arribere et al. 2014;
Kim et al. 2014; Ward 2015). By restricting PCR screening to
these animals, co-CRISPR can substantially reduce the num-
ber of animals that need to be screened [to only a few dozen
in the best cases (Farboud and Meyer 2015; Paix et al.
2015)]. Co-CRISPR is the screening strategy of choice for
modifications generated using short-range HDR.
For co-CRISPR to work well, the desired modification
needs to occur with high efficiency relative to the marker
mutation; if the marker mutation is efficient but the desired
modification is inefficient, most marked F1’s will lack the
mutation of interest. Thus, co-CRISPR is best suited to gen-
erating modifications that are (1) produced by short-range
HDR, which is efficient on a per-F1 basis; (2) induced by a
highly active sgRNA; and (3) introduced as close as possible
to the cut site.
Several different marker mutations have been tested for
co-CRISPR applications (Arribere et al. 2014; Kim et al. 2014;
Ward 2015). Themost effective of these are the gain-of-function
dpy-10(cn64) and sqt-1(e1350)mutations (Figure 3A) (Arribere
et al. 2014) or rescue of the temperature-sensitive lethal pha-
1(e2123) mutation (Figure 3B) (Ward 2015). Since these
marker mutations produce dominant phenotypes, they can be
recognized in the F1 progeny of the injected animals, which
are then screened by PCR (see PCR screening section) to
identify animals carrying the desired modification. Then, F2
progeny of successfully edited animals are genotyped to iden-
tify homozygotes. During this F2 screening step, the dpy-
10(cn64) or sqt-1(e1350)markermutations can be eliminated
by pickingwild-type animals (Figure 3A), provided the desired
edit and marker mutation are unlinked. When using pha-1 for
co-CRISPR, the marker “mutation” is the wild-type allele of
pha-1, which must be genotyped along with the desired mu-
tation to identify homozygotes (Figure 3B).
A unique advantage of co-CRISPR compared to other
screening strategies reported todate is theability tomultiplex:
that is, to simultaneously generate edits at two different loci
(Paix et al. 2015;Ward 2015) or two different edits at a single
locus (Paix et al. 2014) from one batch of injections. Although
one can also obtain doubly edited worms by editing two loci
sequentially (for example, Arribere et al. 2014) or by gener-
ating two alleles separately and then crossing them together,
multiplexing may save time in some cases.
Positive selectable markers
To identify genome modifications produced by long-range
HDR, a selectable marker is typically introduced into the
genome along with the desired modifications. Selection al-
lows one to interrogate all progeny from a batch of injections
(on the order of 10,000 in a typical experiment) without PCR
screening, and thus it is the least labor-intensive strategy for
identifying relatively rare long-range HDR events. Selection
has a very high success rate in our experience (.95%
of projects have succeeded in producing the desired edit,
with 80% of these succeeding on the first batch of injec-
tions, for .50 different loci targeted in our laboratory). The
high success rate is probably due to at least two factors. First,
selection-based strategies use the long-range HDR mecha-
nism, which is insensitive to variations in sgRNA efficiency
(Dickinson et al. 2015) and to distance from the cut site up to
at least 1 kb (Dickinson et al. 2013; Das et al. 2015; Sullivan-
Brown et al. 2016; and our unpublished results). Second,
selection allows recovery even of rare edits.
Several different selectable markers have been used in ge-
nome editing experiments, including unc-119(+) (Dickinson
et al. 2013; Kim et al. 2014), blasticidin resistance (Kim et al.
2014), hygromycin resistance (C. Chen et al. 2013; Dickinson
et al. 2015), and neomycin (G418) resistance (Norris et al.
2015). Using the hygromycin resistance gene (Greiss and Chin
2011) as a starting point, we recently developed a selectable
marker that we refer to as a self-excising cassette (SEC)
(Dickinson et al. 2015) (Figure 4). SEC consists of three parts:
(1) a drug resistance gene, which allows genome modifica-
tions to be made directly in a wild-type background (or any
genetic background desired), using selection; (2) a dominant
phenotypic marker [we used sqt-1(e1350)] that allows one to
identify homozygous insertions and marker excision events
easily based on plate phenotype alone; and (3) an inducible
Cre recombinase. Upon induction of Cre expression by heat
shock, the entire selection cassette is removed from the ge-
nome (hence the term “self-excising”). This eliminates the
need for a second injection step to deliver Cre.
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We and others have generated publicly available vectors
in which SEC is placed within a synthetic intron of a fluores-
cent protein tag. This creates an FP–SEC module that can be
inserted at any desired location in the genome, and after SEC
removal, the remaining LoxP site is left in a synthetic intron
within the fluorescent protein tag. Thus, no residual sequence
is left in the genome outside of the fluorescent protein. These
vectors also include ccdB negative selection markers for effi-
cient insertion of homology arms (see Producing dsDNA repair
templates from preexisting vectors, below). Taking the design
principles of SEC as a starting point, it should be straightfor-
ward to substitute othermarkers for the hygromycin resistance
gene and sqt-1(d) marker used in our vectors.
Because SEC contains transcriptional terminators, in-
sertion of a fluorescent protein–SEC module at the 59 end
produces a loss-of-function mutation that is also a tran-
scriptional reporter. The resulting allele converts to an
N-terminal fluorescent protein tag after SEC removal. Thus,
this approach can be used to generate a loss-of-function
mutation, a promoter fusion, and a protein fusion in a single
injection step.
Construction of Repair Templates for HDR
HDRisused toproduceprecisegenomeedits, in contrast to the
random indels that are generated by error-prone repair. HDR
can be performed using either single-stranded DNA oligonu-
cleotides or double-stranded DNA molecules as homologous
repair templates (Figure 2). Single-stranded DNA (ssDNA)
repair templates are used to produce small, precise edits
(e.g., point mutations), while double-stranded DNA (dsDNA)
repair templates can be used to produce larger modifications.
Linear repair templates with 30- to 40-bp homology arms are
substrates for short-range HDR, while plasmid repair tem-
plates with 500- to 1500-bp homology arms are used for
long-range HDR. Design considerations for each type of re-
pair template are discussed separately.
Designing ssDNA oligo repair templates
ssDNA repair templates consist of the genomemodification(s)
of interest flanked by 30-80 nt of unmodified DNA sequence
(Paix et al. 2014; Zhao et al. 2014; Ward 2015). The longest
commercially available ssDNA oligonucleotides available as
of this writing are Ultramer oligos from Integrated DNATech-
nologies, which can be up to 200 nt in length. Thus, ssDNA
repair templates can in principle be used to produce inser-
tions or substitutions up to 140 nt in size (200 nt minus 30
nt for each homology arm) or precise deletions of at least
several kilobases (Paix et al. 2014).
A published protocol (Paix et al. 2014) includes a detailed
set of instructions for designing ssDNA repair templates. In
brief, an ssDNA repair template has four parts:
Figure 3 Genetic schemes for co-
CRISPR screening. (A) dpy-10 co-CRISPR
(Arribere et al. 2014) makes use of the
dominant Roller phenotype conferred by
the cn64 mutation to identify a desired
modification at an unlinked locus. Be-
cause dpy-10(cn64)/dpy-10(o) animals
have a different phenotype than dpy-
10(cn64)/+, a wild-type copy of dpy-10
can be carried through the screening,
eliminating the need for outcrossing to
remove the marker mutation. The sqt-1
(e1350) marker mutation can be used in
place of dpy-10(cn64). (B) pha-1 co-
CRISPR (Ward 2015) uses repair of the
temperature-sensitive lethal mutation
pha-1(e2123) for live/dead screening
of F1’s. No outcrossing is required be-
cause the converted pha-1 allele is wild
type; however, F2’s need to be PCR
genotyped for both the desired modifi-
cation and pha-1(+).
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Figure 4 Gene tagging with a self-excising selection cassette. (A) Design of a self-excising cassette for drug selection. SEC consists of a drug resistance
gene (hygR), a visible marker [sqt-1(d)], and an inducible Cre recombinase (hs::Cre). SEC is flanked by LoxP sites and placed within a synthetic intron in
an FP::3xFlag tag, so that the LoxP site that remains after marker excision is within an intron. (B) Illustration of the organization of the his-72 locus and
the predicted transcripts from this gene before editing (top), after homologous recombination (middle), and after SEC removal (bottom).
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1. The homology arms are designed similarly regardless of
the modification being made and comprise 30–80 nt of
unmodified sequence at each end of the ssDNA oligo.
2. One needs to ensure that Cas9 cannot cut the modified
locus; otherwise, after HDR occurs, repeated rounds of
cleavage and repair will ultimately lead to the formation
of an indel or random mutation rather than the precise
genome modification desired. In some cases, the desired
mutation already disrupts the Cas9 target site (for exam-
ple, an insertion or deletion can disrupt or eliminate the
target sequence). If the desired mutation leaves the Cas9
target site intact, then additional mutations must be in-
troduced to block Cas9 cleavage. In these cases, it is best to
select a Cas9 target site that resides within a protein-coding
sequence, since silent (synonymous) substitutions can be
introduced to block the Cas9 cleavage without otherwise
affecting the activity of the gene of interest.Where possible,
the simplest approach is to mutate the PAM, since a single
substitution in the PAM is sufficient to completely block
cleavage. If the PAM cannot be mutated without introduc-
ing an amino acid substitution, then the next best choice is
to make multiple synonymous substitutions in the guide
sequence. We generally make as many mutations as possi-
ble, and we consult a codon usage table (Carbone et al.
2003) to ensure that the mutations we make minimally
perturb the codon optimality of the target sequence.
3. If one intends to screen by RFLP (see PCR screening,
above), then a unique restriction site must be included.
4. Finally, the repair template must include the desired ge-
nome modification.
PAGE purification of repair oligos is not essential but has
been reported to increase efficiency (Ward 2015).
Producing dsDNA repair templates from
preexisting vectors
To produce insertions or substitutions.140 bp in length, a
double-stranded homologous repair template is required.
PCR products carrying 30- to 60-bp homology arms are effi-
cient substrates for short-range HDR (Paix et al. 2014, 2015),
while long-range HDR requires homology arms 500–1500 bp
that are typically cloned into a plasmid (C. Chen et al. 2013;
Dickinson et al. 2013, 2015; Arribere et al. 2014; Kim et al.
2014). In either case, the repair template must include mu-
tations to prevent Cas9 cleavage (see Designing ssDNA oligo
repair templates).
Fluorescent protein insertion (the most common applica-
tion that requires dsDNA repair templates) can be accom-
plished via either short-range or long-range HDR (Dickinson
et al. 2013, 2015; Paix et al. 2014, 2015). For short-range
HDR, homology arms can be incorporated into PCR primers
that amplify the DNA to be inserted, and the resulting PCR
product can be purified and used as the repair template (Paix
et al. 2014, 2015).
For long-range HDR, homology arms must be cloned into
a vector to produce a plasmid repair template (Dickinson
et al. 2015). To simplify the process of cloning homology
arms, we developed a cloning procedure based on ccdB neg-
ative selection (Figure 5) (Dickinson et al. 2015). Vectors
carrying different fluorescent protein–SEC modules flanked
by ccdB markers are available via Addgene. To insert homol-
ogy arms into one of these constructs, the vector is first
digested with restriction enzymes to release the ccdB
markers. Then, homology arms are inserted in place of the
ccdB markers, using Gibson assembly (Gibson et al. 2009).
Because ccdB is toxic to standard cloning strains of E. coli,
only clones in which the ccdB markers have been replaced
by the homology arms will grow. These clones can be identi-
fied by direct sequencing, without screening for inserts.
Since any sequence can be cloned in place of the ccdB
markers (Figure 5), this same basic cloning strategy can be
used to build a repair template for any genome engineering
project that will utilize SEC selection. To include additional
modifications beyond the built-in FP tag, one simply needs to
insert a larger DNA fragment comprising both the homology
arm and any additional modifications in place of the ccdB
marker. In general, any sequence located between the Cas9
cleavage site and the selectable marker is guaranteed to be cop-
ied into the genome. Therefore, when designing complex ge-
nomemodifications, choose the Cas9 target site in such away
that the desiredmodifications lie between the cut site and the
selectable marker.
An alternative, high-throughput method for assembling
repair template plasmids was recently described by Schwartz
and Jorgensen (2016; Figure 5B). Their approach, referred to
as “SapTrap,” is based on the Golden Gate assembly
method (Engler et al. 2008), which allows multiple DNA frag-
ments to be joined together in a single reaction tube. SapTrap
adds homology arms to pre-existing building blocks that can
include various FP and epitope tags, selectable markers, and
modules for sophisticated applications such as conditional tag-
ging. The SapTrap destination vector also contains a second
acceptor site for the guide sequence, eliminating the need to
clone a separate sgRNA expression plasmid. A significant
advantage of the modular SapTrap approach is that it allows
a large variety of different repair constructs to be built by simply
selecting the appropriate building blocks for a given application.
The original SapTrap publication did not incorporate SEC selec-
tion (Schwartz and Jorgensen 2016), but a SapTrap-compatible
SEC module is under construction as of this writing.
Building more complex repair templates using
Gibson assembly
Although modular SEC constructs simplify the construction
of repair templates for many genome engineering projects,
some very complex custom modifications might still require
generationof anewhomologous repair template fromscratch.
When designing novel repair strategies, again the cardinal
rule is that any sequence located between the Cas9 cleavage
site and the selectable marker is guaranteed to be copied into
the genome. Our preferred method for building new homol-
ogous repair templates is Gibson assembly (Gibson et al. 2009).
894 D. J. Dickinson and B. Goldstein
In this cloning method, linear DNA fragments (most commonly
PCR products) that overlap by 20–30 bp at their ends are co-
valently joined together. The requisite 20- to 30-bp overlaps are
easily incorporated into the PCR primers that are used to gen-
erate the individual fragments. We prefer Gibson assembly over
other cloning methods for two reasons: first, Gibson assembly
does not require the addition of any extra sequences such as
restriction sites or recombination targets; and second, up to six
fragments can be assembled in a single step.
For researchers who are new to Gibson assembly, the
following tips may be helpful:
1. We obtain the highest rates of successful assembly using
fragments that overlap by 30 bp.
2. We often use PCR to amplify the vector backbone and
include it as one of the fragments in the assembly.
The most common cause of failure with this approach is
large amounts of parent vector that carry through to the
transformation. To avoid this, treat the vector PCR prod-
uct with DpnI and gel purify it. If vector background still
persists, reduce the amount of plasmid template used in
the PCR reaction that generates the vector backbone.
3. When gel purifying DNA fragments for use in a Gibson
assembly reaction, avoid using ethidium bromide or sim-
ilar stains to visualize bands, since both ethidium bromide
and UV radiation cause DNA damage that can significantly
reduce cloning efficiencies. Instead, add 8 mg/ml crystal
violet to the agarose gel, which allows DNA bands to be
visualized under ambient light without UV exposure.
4. Since Gibson assembly joins DNA fragments covalently,
1 ml of a completed Gibson assembly reaction can be used
as template for PCR to amplify the assembled product. We
sometimes get better results by amplifying an assembled
product and then ligating it into a vector, rather than in-
cluding the vector directly in the assembly reaction.
5. If a multifragment Gibson assembly fails, try a sequential
assembly strategy: assemble pairs of fragments, amplify
and gel purify the resulting products, and then use those
products as fragments in another assembly reaction.
Figure 5 (A) Gibson assembly-based strategy (Dickinson et al. 2015). An FP–SEC vector is digested to release ccdB markers, and homology arms are
inserted by Gibson assembly to generate the repair template plasmid. Since the ccdB-containing parent vector does not transform, correct clones make
up a majority of transformants and can be identified directly by sequencing. (B) SapTrap assembly strategy (Schwartz and Jorgensen, 2016). Homology
arms and the sgRNA sequence are assembled, along with pre-existing tag and selectable marker building blocks, into a destination vector. The Type II
restriction enzyme SapI generates unique overhangs that ensure ligation of the various fragments in the correct order.
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Addressing Cas9 Specificity
TheabilityofCas9to recognizeaspecific target in thecontextofa
complex genome is remarkable. Nevertheless, this specificity is
not absolute; in mammalian systems and in vitro, Cas9 has been
observed to cleave substrates that do not perfectly match the
guide sequence (Jinek et al.2012; Fu et al.2013;Hsu et al.2013;
Pattanayak et al. 2013). These results call for an appropriate
degree of caution when using Cas9 as an experimental tool.
Two studies have examined Cas9 specificity in C. elegans
via whole-genome sequencing of mutant animals (Chiu et al.
2013; Paix et al. 2014), and two additional studies looked for
evidence of off-target activity of Cas9 by sequencing candidate
loci that closely matched the guide sequence (Dickinson et al.
2013; Friedland et al. 2013). None of these experiments de-
tected any evidence of bona fide off-target mutations induced
by Cas9, suggesting that in C. elegans, off-target mutations gen-
erated by Cas9 are uncommon. However, the two whole-
genome sequencing studies both found evidence of other
“passenger” mutations in CRISPR strains, at sites with no
sequence similarity to the Cas9 target site. These second-site
lesions are most likely spontaneous mutations that arose
before or during strain construction. To avoid confounding
effects of these passenger mutations on subsequent experi-
ments, it should be standard practice to outcross mutant
alleles and to isolate and characterize at least two indepen-
dent alleles of every experimental genome modification.
The ease and efficiency of Cas9-based approaches are such
that isolating multiple alleles of each modification does not
represent a significant burden. As variant Cas9 proteins rec-
ognizing different PAMs become available (Bell et al. 2015;
Kleinstiver et al. 2015; Ran et al. 2015), the specificity of
these enzymes will need to be carefully characterized.
When performing HDR, a second potential confounding
issue is the incompleteor incorrect copyingof the repair template
into the genome. Rearrangements have been reported during
homologous recombination from dsDNA templates (Berezikov
et al. 2004; Frøkjaer-Jensen et al. 2008; Dickinson et al. 2013,
2015). Using plasmid repair templates, the frequency of
rearrangements is 5–10% that of recombinant alleles in
our experience. With short-range HDR, the repair template
may be incompletely copied into the genome. Partial copying
appears to occur stochastically (Arribere et al. 2014; Ward
2015) but is more frequent at larger distances from the cut site.
Point mutations can occur in the repair template, due to mis-
takes in oligo synthesis (for the ssDNA oligo repair template),
PCR errors (for dsDNA templates generated by PCR), or the
DNA repair machinery responsible for HDR. Again, a straight-
forward solution to all of these issues is to isolate and character-
ize multiple independent alleles for each genome modification.
Recommended Strategies for Different Types of
Modifications
In this section, we provide our recommendations for gener-
ating common types of genomeedits, taking into account all of
the information from the preceding sections. These recom-
mendations are based on published information, but also
reflect our personal preferences to some extent. There are
now multiple valid strategies to generate most kinds of edits,
and these recommendations should be taken only as our
suggestions for “what to try first.” Figure 6 shows a flow chart
summarizing the recommendations.
Null mutations
A null mutation is a useful starting point for the analysis of
almost anygene. By ascertaining thenull phenotypeof a gene,
one establishes a basis for comparison when making targeted
mutations later on. In addition, it is valuable to know the null
phenotype of a gene when evaluating fluorescent protein
knock-in strains: if a knock-in strain exhibits a phenotype
similar to the null, this indicates that fusion to the fluorescent
protein compromises the gene’s function. At least four differ-
ent strategies can produce null (or strong loss-of-function)
mutations:
1. Error-prone end-joining repair can be used to produce
indels near the 59 end of a gene, resulting in frameshift
and early termination. This approach is useful for gener-
ating tissue-specific phenotypes (Shen et al. 2014) and
might be adaptable to high-throughput screening based
on feeding (Liu et al. 2014). However, an end-joining
event leaves the majority of the gene’s coding sequence
intact, and thus it is difficult to guarantee a priori that an
indel mutation will be a bona fide null allele. Random
indel mutations are also more difficult to screen for by
PCR thanHDRmutations (which can incorporate a restric-
tion site to facilitate RFLP). Therefore, as a general rule,
we prefer to use HDR to produce null mutations in which
the entire coding sequence of a gene is deleted.
2. Paix et al. (2014, 2015) showed that gene-sized dele-
tions could be generated by end joining, by using two
sgRNAs that cut at opposite ends of the region to be
deleted. More precise deletions could be generated by
adding an ssDNA oligo with homology to the two ends of
the deletion. In either case, the entire coding sequence
of the gene is eliminated, which formally eliminates the
possibility that any gene products will be produced. The
same approach can also be used to delete portions of
genes.
3. When a fluorescent protein–SEC module is inserted at the
59 end of a gene of interest, the SEC separates the pro-
moter from the protein-coding sequence of the gene,
resulting in a loss-of-function allele (Dickinson et al.
2015). This loss-of-function allele is a useful intermediate
in the construction of an N-terminal protein tag. However,
N-terminal fluorescent protein–SEC insertions are not true
genetic null mutations, in part because spontaneous SEC
excision (resulting in expression of the gene of interest)
occurs in certain tissues (Dickinson et al. 2015).
4. The SEC-based strategy can also be used to generate a
bona fide null mutation by replacing the entire coding
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sequence of a gene with the fluorescent protein–SECmod-
ule. We have generated deletions of up to 9 kb using a
single sgRNA and selection, but using two sgRNAs (one at
each end of the region to be deleted) is expected to in-
crease efficiency. The visible phenotype conferred by SEC
makes it trivial to maintain the null allele as a heterozy-
gote, which facilitates isolation and subsequent balanc-
ing of null mutations in essential genes. SEC can be used
to facilitate mutant isolation and balancing and then
eliminated once a stable strain is in hand, yielding an
allele in which the coding sequence of the gene of inter-
est is replaced by a fluorescent protein. The resulting
allele functions both as a null mutation and as a tran-
scriptional reporter (promoter fusion).
Recommendation: Use two sgRNAs and an oligonucleotide
repair template, with co-CRISPR screening, when a clean de-
letion of a gene (or part of a gene) without insertion of any
exogenous sequence is desired (Paix et al. 2015). Use the
SEC-based strategy when insertion of a fluorescent protein
in place of the gene’s coding sequence is desired (Dickinson
et al. 2015).
Point mutations
By “point mutations” we mean substitutions, insertions, or
deletions of one or a few amino acids that can be easily
templated by an ssDNA oligo. Although a selection-based
strategy with long-range HDR can produce point mutants
(Dickinson et al. 2013), this approach is overkill since short-
range HDRwith co-CRISPR can efficiently produce point mu-
tations with minimal need for PCR screening (Kim et al.
2014; Arribere et al. 2014). Also, the co-CRISPR strategy
allows one to make substitutions in the middle of genes,
where integration of a selectable marker could be problem-
atic. Finally, a co-CRISPR approach could allow multiple
point mutations to be produced simultaneously (Paix et al.
2015; Ward 2015).
Recommendation: For point mutations, use ssDNA-based
HDR, with dpy-10, sqt-1, or pha-1 co-CRISPR and RFLP
for screening (Arribere et al. 2014; Paix et al. 2015; Ward
2015).
Fluorescent protein fusions
Fluorescent protein fusions canbeproduced either byusing the
SEC-based strategy (Dickinson et al. 2015) or by short-range
Figure 6 Flow chart summarizing recommended CRISPR techniques for different applications. See Recommended Strategies for Different Types of
Modifications for details and rationale behind these recommendations.
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Figure 7 A general strategy for structure–function analysis. (A) Illustration of the strategy. First, a null mutation is generated by inserting FP–SEC in place
of the gene of interest; then, variants are reintroduced into the mutant background. Once the null mutant is made, multiple different variants (as many
as desired) can be introduced using the same homology arms and sgRNA for the second HDR step. (B) Genetic scheme for executing this strategy for a
nonessential gene. (C) Genetic scheme for executing this strategy for an essential gene. The only additional step is the introduction of a balancer
chromosome during isolation of the initial null mutant.
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HDR with a PCR product repair template and co-CRISPR
(Arribere et al. 2014; Kim et al. 2014; Paix et al. 2015). In
our experience, these two approaches are very similar in
terms of both the total time and hands-on labor required.
The SEC strategy requires more work up front because of
the need to clone homology arms in to the SEC vector, but
the actual isolation of knock-in animals is easier. The co-
CRISPR approach is quicker initially because the repair
template is a PCR product and no cloning is required, but
isolating knock-ins takes more work because PCR screening
of 50–100 animals is needed. Thus, which strategy one
chooses is largely a matter of personal preference. We prefer
the SEC strategy in most cases, for two reasons: first, when
used to generate N-terminal tags, the SEC-based strategy
produces both a fluorescent protein fusion and a loss-of-
function mutation from a single injection step. The loss-of-
function intermediate is useful because one can quickly
determine whether the tagged protein is functional by com-
paring the loss-of-function phenotype to the phenotype of the
fluorescent protein fusion. Second, because it employs long-
range HDR, the SEC strategy is insensitive to sgRNA effi-
ciency and can produce insertions at a greater distance from
the cut site, allowing more flexibility in experimental design.
Recommendation:Use theSEC-basedstrategy forfluorescent
protein fusions (Dickinson et al. 2015).We suggestmaking an
N-terminal fusion unless there is a specific reason to choose a
C-terminal fusion instead, because the process of generating
an N-terminal fusion also yields a useful loss-of-function
intermediate.
Other changes
Although the kinds of modifications above are the most
common, they only scratch the surface of what is possible
using Cas9-triggered homologous recombination. For exam-
ple, simultaneous cutting on two chromosomes can produce
custom translocations that function as balancer chromo-
somes (Chen et al. 2015). We can also imagine, for example,
inserting LoxP or FLP recombinase target (FRT) sites to gen-
erate conditional alleles or replacement of whole genes by
their homologs from other species to probe evolutionary
questions. The methods one chooses to use for these or
other kinds of experiments will depend on the details of
the experiment, but as a general rule, we suggest that
short-range HDR with co-CRISPR screening be used for all
modifications that can be templated by an ssDNA oligo,
while long-range HDR with SEC selection is best suited for
making larger changes. SEC or other selectable markers can
be incorporated into custom repair templates, using Gibson
assembly.
A general strategy for dissecting gene function
A common task for any protein of interest is to determine how
different domains, binding sites, sequence motifs, or other
features contribute to the function of the protein as a whole.
Often this involves making many different mutants in a gene
of interest and assaying their function. C. elegans is especially
well suited to such “structure–function” analysis because of its
short generation time, rich cell biology, defined lineage, and
nowwith CRISPR, the ease of generatingmanymutants in the
endogenous locus, without the need for overexpression. We
have devised a simple, general strategy for performing
structure–function analysis of C. elegans genes, which we
demonstrated in Das et al. (2015) and describe here.
Briefly, we begin by making a null mutation and then
reinsert either a wild-type or a mutant version of the gene
of interest at the endogenous locus (Figure 7). The advantage
of this strategy is that one can generate variants of the gene of
interest in vitro, using standard cloning procedures, rather
than designing a new CRISPR approach to produce each var-
iant. Once the initial null allele is in hand, the same sgRNA,
homology arms, and screening strategy can be used to
reinsert each variant back into the endogenous locus. The
phenotype of each variant can then be examined and
compared directly to the null.
We generate the null mutation by inserting a fluorescent
protein–SEC module in place of the coding sequence (see
Null mutations section, strategy 4) and then removing SEC.
In principle, the null allele could also be generated by co-
CRISPR with two sgRNAs and an oligonucleotide repair tem-
plate. In parallel, we clone the genomic sequence of the gene
of interest into an SEC-containing vector to generate a rescue
construct. Mutations can be made to this rescue construct,
using standard cloning techniques such as site-directed mu-
tagenesis. If the gene of interest is nonessential, the (possibly
mutated) rescue construct can be introduced directly into the
homozygous null mutant in a second homologous recombi-
nation step. To generate multiple variant versions of a gene,
one needs only to repeat the second recombination step for
each variant. Figure 7, A and B, shows a detailed schematic of
this procedure.
For essential genes, the workflow requires only one simple
modification (Figure 7C). After generating the null allele,
we mate it to a balancer and then remove the SEC. Variant
versions of the gene are then introduced directly into the bal-
anced null mutant background. By using an sgRNA targeting
the fluorescent protein present in the null allele, we ensure
that recombination occurs only on the null chromosome and
not on the balancer. The resulting variant, like the parent null
allele, is immediately balanced; any phenotypic assays are
done using the fraction of progeny that have lost the balancer
and are homozygous mutant.
Where to Go for More Information and Detailed
Protocols
Detailed protocols are provided by several of the primary
articles that established these methods (Dickinson et al.
2013, 2015; Arribere et al. 2014; Paix et al. 2014, 2015). In
addition, wemaintain a website (http://wormcas9hr.weebly.
com) with up-to-date protocols that have been tested in our
laboratory.
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